Reflections on 2022 from our CEO
As we enter a new year it is always good [...]
QureTech Bio receives excellent support for development of new antibiotics
The support is received from the Swedish Research Council's major [...]
Reflection from QureTech Bio’s CEO
A reflection over the last year and looking forward! My [...]
QureTech Bio founders in major US investment to combat antibiotic resistance
Researchers at Washington University School of Medicine in St. Louis [...]
QureTech Bio expands workforce following major investment
Umeå-based pharmaceutical development company QureTech Bio is hiring more people [...]
QureTech Bio Looks to the Future With Appointment of New CEO
Umeå-based biotech company QureTech Bio has appointed Helén Fält as [...]
Professor Scott Hultgren, CSO of QureTech Bio, elected fellow of the National Academy of Inventors
Scott Hultgren, CSO of QureTech Bio and Helen L. Stoever [...]
Umeå researcher wants to save millions of lives with new antibiotics
Fredrik Almqvist, CEO of QureTech Bio based in Umeå in [...]
QureTech Bio secures SEK 14 million investment – a very important milestone in their fight against antibiotic resistance
Venture capital company Nascent Invest has bought shares in Umeå-based [...]
QureTech Bio has secured a US patent for tuberculosis treatment
Umeå-based QureTech Bio has received preliminary approval for a patent [...]